Brown Advisory Inc. Increases Position in Novanta Inc. $NOVT

Brown Advisory Inc. increased its stake in Novanta Inc. (NASDAQ:NOVT) by 0.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 544,172 shares of the technology company’s stock after purchasing an additional 3,901 shares during the quarter. Brown Advisory Inc. owned 1.52% of Novanta worth $64,751,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in NOVT. Allspring Global Investments Holdings LLC boosted its position in shares of Novanta by 75.9% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,399,462 shares of the technology company’s stock worth $155,536,000 after buying an additional 604,055 shares in the last quarter. GW&K Investment Management LLC raised its stake in Novanta by 187.3% in the 4th quarter. GW&K Investment Management LLC now owns 736,954 shares of the technology company’s stock valued at $87,691,000 after purchasing an additional 480,413 shares during the last quarter. Norges Bank acquired a new position in Novanta in the 4th quarter valued at about $50,719,000. Schroder Investment Management Group raised its stake in Novanta by 206.1% in the 4th quarter. Schroder Investment Management Group now owns 600,146 shares of the technology company’s stock valued at $72,540,000 after purchasing an additional 404,097 shares during the last quarter. Finally, Barrow Hanley Mewhinney & Strauss LLC raised its stake in Novanta by 217,908.2% in the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 346,633 shares of the technology company’s stock valued at $41,246,000 after purchasing an additional 346,474 shares during the last quarter. 98.35% of the stock is currently owned by hedge funds and other institutional investors.

Novanta Stock Performance

NASDAQ NOVT opened at $160.53 on Monday. Novanta Inc. has a 12 month low of $98.27 and a 12 month high of $171.85. The company has a 50-day moving average of $143.11 and a 200-day moving average of $132.85. The company has a debt-to-equity ratio of 0.15, a current ratio of 3.56 and a quick ratio of 2.69. The company has a market cap of $5.72 billion, a P/E ratio of 116.33 and a beta of 1.67.

Novanta (NASDAQ:NOVT) last posted its quarterly earnings data on Monday, May 11th. The technology company reported $0.81 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.03. Novanta had a net margin of 5.35% and a return on equity of 12.06%. The company had revenue of $257.71 million during the quarter, compared to the consensus estimate of $253.40 million. During the same quarter in the prior year, the company posted $0.74 EPS. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. As a group, equities analysts predict that Novanta Inc. will post 3.59 earnings per share for the current year.

Insider Activity at Novanta

In other news, CEO Matthijs Glastra sold 7,500 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $150.43, for a total transaction of $1,128,225.00. Following the completion of the transaction, the chief executive officer owned 42,761 shares of the company’s stock, valued at $6,432,537.23. This represents a 14.92% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.20% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on the stock. Wall Street Zen downgraded shares of Novanta from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Weiss Ratings reissued a “hold (c-)” rating on shares of Novanta in a research note on Friday, April 17th. Finally, Robert W. Baird set a $180.00 target price on shares of Novanta in a research note on Tuesday, June 9th. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $180.00.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.